Author:
Alderman E L,Davies R O,Crowley J J,Lopes M G,Brooker J Z,Friedman J P,Graham A F,Matlof H J,Harrison D C
Abstract
Seventeen patients received placebo medication during a 12-week run-in period, followed by four double-blind study periods of six weeks each, during which time placebo, 80 mg, 160 mg and 320 mg propranolol dosages were administered. Examination of the frequency of angina episodes and nonprophylactic nitroglycerin consumption revealed significant beneficial clinical responses for both the 160 and 320 mg dosages. Exercise testing also demonstrated increased exercise tolerance (320 mg dose) with a shift of the exercise end point from pain to fatigue in seven of 17 patients. The interrelationships between propranolol daily dosage, clinical response assessed by percent reduction in anginal episodes, beta-adrenergic blockade measured by percent reduction in exercise heart rate and serum levels were examined. In general, serum levels of 30 ng/ml, when drawn 90 to 180 minutes following the last oral dose, were required to achieve a 25% or greater reduction in angina frequency. Serum levels above 30 ng/ml were similarly correlated with a 20% or greater reduction in exercise heart rate at equivalent levels of exercise. Detailed examination of different patterns of clinical response with respect to beta-blockade, serum levels and oral doses are presented.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference23 articles.
1. com.atypon.pdfplus.internal.model.plusxml.impl.AuthorGroup@57f26e1c
: Beta-adrenergic blockade in the management of angina pectoris. In Circulatory Effects and Clinical Uses of Beta-Adrenergic Blocking Drugs edited by HARRISON DC. Amsterdam Excerpta Medica 1971 p 67
2. com.atypon.pdfplus.internal.model.plusxml.impl.AuthorGroup@59359a92
: A critical review of the symptomatic electrocardiographic and circulatory effects of adrenergic beta-receptor antagonists in angina pectoris. In New Perspectives in Beta-Blockade edited by BURLEY DM FRIER JH RANDEL RK TAYLOR SH. Horsham England CIBA Laboratories 1973 p 129
3. Propranolol in Patients with Angina Pectoris
4. Multicenter trial of propranolol in angina pectoris
5. Plasma propranolol levels in adults With observations in four children
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献